Table 3.
Number of participants recieving co-interventions prior to, during, and at the end of the 48-hour study
| Number of Participants | |||
|---|---|---|---|
| Prior | During | End | |
| Antibiotics | 9 | 8 | 6 |
| Surfactant | 8 | 1 | 0 |
| Dopamine | 9 | 8 | 5 |
| Dobutamine | 4 | 3 | 0 |
| Hydrocortisone | 5 | 6 | 2 |
| Epinephrine | 2 | 3 | 1 |
| Sildenafil | 1 | 0 | 0 |
| Paralytic | 7 | 5 | 2 |
| Dexamethasone | 2 | 1 | 1 |